Promising Medical Stocks To Keep An Eye On - September 29th

Key Points

• Merus, UnitedHealth Group, and Eli Lilly are highlighted as the top medical stocks to watch due to significant trading volume and involvement in the healthcare sector.
• Merus N.V. is focused on developing antibody therapeutics, with its key candidate Zenocutuzumab currently in clinical trials for various cancer treatments.
• UnitedHealth Group operates a diversified health care model in the U.S., providing a range of services including health benefit plans and programs for underserved populations.

Merus, UnitedHealth Group, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly traded companies involved in the healthcare sector, including pharmaceuticals, biotechnology, medical devices and equipment, and healthcare service providers. By investing in these equities, shareholders gain exposure to advances in drug development, medical technology, and patient care. Their performance is often driven by factors such as clinical trial results, regulatory approvals, patent expirations, and changes in healthcare policy. These companies had the highest dollar trading volume of any Medical stocks within the last several days.

Merus (MRUS)

Merus N.V., a clinical-stage immuno-oncology company, engages in the development of antibody therapeutics in the Netherlands. Its bispecific antibody candidate pipeline includes Zenocutuzumab (MCLA-128), which is in a phase 2 clinical trials for the treatment of patients with metastatic breast cancer and castration-resistant prostate cancer, as well as in Phase 1/2 clinical trials for the treatment of solid tumors that harbor Neuregulin 1.

Read Our Latest Research Report on MRUS

UnitedHealth Group (UNH)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read Our Latest Research Report on UNH

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY